欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号SE/H/1856/001
药品名称Salmeterol/Fluticasone Neutec
活性成分
    • fluticasone propionate 500.0 µg
    • salmeterol xinafoate 50.0 µg
剂型Inhalation powder, pre-dispensed
上市许可持有人Neutec Inhaler Ireland Limited
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • Germany (DE)
      Salmeterol/Fluticasonpropionat Wellnex 50 Mikrogramm/500 Mikrogramm einzeldosiertes Pulver zur Inhalation
    • Denmark (DK)
    • Netherlands (NL)
    • Iceland (IS)
      Salmeterol/Fluticasone Wellnex 50 míkróg/500 míkróg/skammt Innöndunarduft, afmældir skammtar
    • United Kingdom (Northern Ireland) (XI)
    • Norway (NO)
      Salmeterol/Fluticasone Wellnex
    • Finland (FI)
    • France (FR)
许可日期2019/09/19
最近更新日期2024/02/23
药物ATC编码
    • R03AK06 salmeterol and fluticasone
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Other Generic application Art 10.3 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase